Person Prof James Denham National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in A clinical trial to determine the optimal timing of androgen deprivation in relapsed or non-curable prostate cancer (funded by National Health and Medical Research Council) Participant in Assessment of rectal and urinary toxicity from the RADAR prostate radiotherapy trial – dosimetric constraints for novel symptom clustering, derivation of radiobiological parameters and assessment of patient localisation effects (funded by National Health and Medical Research Council) Participant in Investigation of a new electronic portal imaging device for radiation therapy dose delivery verification (funded by National Health and Medical Research Council) Principal investigator of Optimal duration of neoadjuvant androgen deprivation therapy in localised prostate cancer (funded by National Health and Medical Research Council) Principal investigator of Optimal duration of neoadjuvant androgen deprivation therapy in localised prostate cancer treated by radiotherapy (funded by National Health and Medical Research Council) View all 11 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in A clinical trial to determine the optimal timing of androgen deprivation in relapsed or non-curable prostate cancer (funded by National Health and Medical Research Council) Participant in Assessment of rectal and urinary toxicity from the RADAR prostate radiotherapy trial – dosimetric constraints for novel symptom clustering, derivation of radiobiological parameters and assessment of patient localisation effects (funded by National Health and Medical Research Council) Participant in Investigation of a new electronic portal imaging device for radiation therapy dose delivery verification (funded by National Health and Medical Research Council) Principal investigator of Optimal duration of neoadjuvant androgen deprivation therapy in localised prostate cancer (funded by National Health and Medical Research Council) Principal investigator of Optimal duration of neoadjuvant androgen deprivation therapy in localised prostate cancer treated by radiotherapy (funded by National Health and Medical Research Council) View all 11 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
